2^nd International Conference and Expo on Lipids: Metabolism, Nutrition & Health October 03-04, 2016 Orlando, Florida, USA

Dr. Sampath Parthasarathy is Florida Hospital Endowed Chair in Cardiovascular Sciences, Professor of Medicine and Associate Director of Research at the Burnett School of Biomedical Sciences at the University of Central Florida. Recipient of van Deeenen Memorial Award, The Ranbaxy award, Special Recognition by the American Heart Association, Jerome Markowitz award, SASAT Life time achievement award, and others. He is also a Member of several Editorial Boards. Research activities are focused on the fundamental mechanisms of the development of atherosclerosis and heart failure. Specifically, he is interested in studying the role of oxidative stress in the development of cardiovascular diseases and associated risk factors including Type 2 diabetes. In addition, he is interested in both the prevention and cure of cardiovascular diseases using nutritional, pharmacological, and life style modulations.

Biomedical Sciences, Cardiology, Type 2 Diabetes,Oxidative stress, Cardiovascular diseases, Atherosclerosis

Carl E. Freter, MD, PhD, FACP is the Director of the Division of Hematology and Oncology at Saint Louis University. He is a tenured Professor of Medicine, Interim Director of the Saint Louis University Cancer Center and the Rosalie Fusz Endowed Chair of Hematology. Dr. Freter is also the Director of the Fellowship Program in Hematology and Oncology. Dr. Freter received his MD and PhD in biochemistry at Washington University School of Medicine. He did his internship and residency training at Stanford University, and his fellowship in hematology/oncology at the National Cancer Institute at the NIH. Before coming to Saint Louis University in 2014, Dr. Freter was the Co-Director of the Ellis Fischel Cancer Center at the University of Missouri-Columbia, as well as the Director of the Division of Hematology and Oncology and the Fellowship Program in Hematology and Oncology. He is one of America’s Top Oncologists and for the last 4 years, been featured in St. Louis Magazine’s Annual Best Doctors of St. Louis issue. He is a member of the American College of Physicians, American Association of Cancer Research, American Society of Clinical Oncology, and American Society of Hematology. In 2014, Dr. Freter was honored at the annual Leukemia/Lymphoma Meeting in St. Louis for assistance in testimony in the passing or the oral chemotherapy parity bill in the state of Missouri. Dr. Freter’s areas of expertise in both clinical and research areas include breast cancer, malignant hematology, leukemia and lymphoma. He has two research laboratories at Saint Louis University engaged in anti-cancer research. Dr. Freter is the President and CEO of his own biotech start-up company, ONCOLYSIS, LLP. He has authored multiple book chapters and articles in peer reviewed journals. He has presented at many international and national conferences and has participated in NIH and industry sponsored research projects. Dr. Freter has received NIH funding on multiple research projects and funding from multiple other outside sources for conducting cancer research.

Breast cancer, Malignant hematology, Leukemia and lymphoma, Oncology, Biochemistry

Dr. Frederic Geissmann gained a medical degree in clinical haematology in 1996 and a PhD in Immunology in 1999, both from the University of Paris (France), and was a Post-doctoral Fellow of Dr Dan Littman in New York from 2000 to 2003. His research is focused on cellular and molecular mechanisms that control the differentiation, maintenance, and physiological functions of macrophages and monocytes and their roles in tissue homeostasis and disease processes. The Geissmann lab is now building on previous work to investigate mechanisms by which tissue macrophages may control tissue growth and metabolism and whether these same mechanisms play a role in cancer initiation and development. He is a recipient of a number of prestigious awards, including the European Young Investigator (Euryi) award, the European Research Council Investigator award and the Wellcome Trust Senior Investigator award.

Differentiation, maintenance, and physiological functions of macrophages and monocytes, Inflammation/inflammatory diseases, Developmental studies, lineage tracing, Genetics, and intra-vital microscopy

George Kokotos is the Chairman of the Department of Chemistry at the University of Athens, Greece. He studied chemistry at the University of Athens where he also obtained his Ph.D. He then conducted postdoctoral work in the Department of Pharmaceutical and Biological Chemistry at the University of London. He has spent a sabbatical leave as a visiting Professor in the Department of Chemistry and Biochemistry at the University of California, San Diego. He has authored over 140 publications in peer-reviewed journals and edited two books on Bioactive Lipids and Lipases. He is also co-inventor of more than 12 patents.

Lipolytic enzyme inhibitors, Phospholipase A2 enzymes, Analgesic and Anti-inflammatory activity, Homoproline analogues, Organic Chemistry, Medicinal Chemistry

Laura Bindila is Head of Lipidomics/Mass Spectrometry Facility at the Institute for Physiological Chemistry, University Medical Center Mainz, where her scientific interest is unravelling the lipid signals involved in various neurobiological processes, and more generally in physiological and pathophysiological states. She is also a member of Research Center for Translational Neuroscience, of the University of Mainz. She has previously worked at Luxembourg Clinical Proteomics, and University of Münster where she has focused on glycoconjugates and (glyco)proteomics in cancer research and rare diseases.

Glycomics, glycoproteomics and (glyco)lipidomics approaches for disease associated biomarker discovery and monitoring; biological processes.

Morgan Fullerton completed his PhD in at the University of Guelph in 2009 in molecular metabolism. Interested in the molecular regulation of phospholipid metabolism, his work uncovered a link between phospholipids and obesity. He then joined the lab of Dr. Greg Steinberg at McMaster University. Supported by a Postdoctoral and Banting Postdoctoral Fellowship from the Canadian Institutes of Health Research (CIHR), his research focused on various aspects of immune cell lipid metabolism and links to whole body insulin sensitivity. In July 2014, Dr. Fullerton joined the department of Biochemistry, Microbiology and Immunology at the University of Ottawa as an assistant professor and is a CIHR New Investigator. The Fullerton lab uses knockout and knock-in mouse models of key metabolic and nutrient regulators and continues to focus on immunometabolism. Dr. Fullerton’s research strives to understand the metabolic regulatory networks in innate immune cells and inflammatory/metabolic cross-talk in metabolic tissues that govern the progression of metabolic diseases such as atherosclerosis, fatty liver disease and type 2 diabetes.

Regulation of Phospholipid Metabolism, Immune cell Lipid Metabolism, Atherosclerosis, Fatty liver disease and Type 2 diabetes

Dr. Morgan Fullerton completed his PhD in at the University of Guelph in 2009 in molecular metabolism. Interested in the molecular regulation of phospholipid metabolism, his work uncovered a link between phospholipids and obesity. He then joined the lab of Dr. Greg Steinberg at McMaster University. Supported by a Postdoctoral and Banting Postdoctoral Fellowship from the Canadian Institutes of Health Research (CIHR), his research focused on various aspects of immune cell lipid metabolism and links to whole body insulin sensitivity. In July 2014, Dr. Fullerton joined the department of Biochemistry, Microbiology and Immunology at the University of Ottawa as an assistant professor and is a CIHR New Investigator. The Fullerton lab uses knockout and knock-in mouse models of key metabolic and nutrient regulators and continues to focus on immunometabolism. Dr. Fullerton’s research strives to understand the metabolic regulatory networks in innate immune cells and inflammatory/metabolic cross-talk in metabolic tissues that govern the progression of metabolic diseases such as atherosclerosis, fatty liver disease and type 2 diabetes.

Phospholipid Metabolism, Cell Lipid Metabolism, Metabolic and Nutrient Regulators, Atherosclerosis, Fatty liver disease and Type 2 diabetes.

In December 2012, he got his PhD degree from Christer S. Ejsing's lipidomics lab at University of Southern Denmark. Here he developed quantitative shotgun lipidomics platform for functional studies of yeast and mammalian cells lipidome. Right, after that he joined Andrej Shevchonko's lab MPI-CBG, Dresden Germany. Here he continued his work on shotgun lipidomics and additionally developed a LC-MS based platform for quantification and discovery of endocannabinoids, small lipids. In 2015, he got offered to start a lipidomics lab at Danish Cancer Society Research Center (DCRC) and since 2015 he have been Head of Lipidomics Core Facility (LCF) at DCRC.

Endocannabinoids, Lipids, Cancer, Yeast cell lipidome, Mammalian cell lipidome

Marica Bakovic completed BSc in Chemistry and PhD in Biological Chemistry at the University of Alberta. She received post-doctoral awards from Medical Research Council and Alberta Heritage Foundation. Before coming to the University of Guelph, she worked in the area of molecular and cell biology of lipid metabolism at the Faculty of Medicine, University of Alberta. Currently, she is Professor in the Department of Human Health and Nutritional Sciences at the University of Guelph. Dr. Bakovic has a long-lasting interest in lipid metabolism and nutrition, especially in the area of regulation of membrane phospholipids, fatty acids, and methyl-group donors.

Regulation of membrane phospholipids, Fatty acids, and Methyl-group donors

Marica Bakovic completed BSc in Chemistry and PhD in Biological Chemistry at the University of Alberta. She received post-doctoral awards from Medical Research Council and Alberta Heritage Foundation. Before coming to the University of Guelph, she worked in the area of molecular and cell biology of lipid metabolism at the Faculty of Medicine, University of Alberta. Currently, she is Professor in the Department of Human Health and Nutritional Sciences at the University of Guelph. Dr. Bakovic has a long-lasting interest in lipid metabolism and nutrition, especially in the area of regulation of membrane phospholipids, fatty acids, and methyl-group donors.

Regulation of membrane phospholipids, Fatty acids, and Methyl-group donors